Product Images Granisetron Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Granisetron Hydrochloride NDC 51991-735 by Breckenridge Pharmaceutical, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - granisetron 01

Chemical Structure - granisetron 01

PRINCIPAL DISPLAY PANEL - 2 Tablet Blister Pack Carton - granisetron 02

PRINCIPAL DISPLAY PANEL - 2 Tablet Blister Pack Carton - granisetron 02

Each tablet of Granisetron Hydrochloride contains 1.12 mg of granisetron hydrochloride USP equivalent to granisetron, 1 mg. It is a medication used to prevent nausea and vomiting caused by cancer chemotherapy and radiation therapy. The suggested dosage is 2 mg once daily or 1 mg twice daily. For chemotherapy administration, two tablets of 1 mg each are taken up to 1 hour before chemotherapy in the 2mg once daily regimen. In the 1 mg twice daily regimen, the first 1 mg tablet is given 1 hour before chemotherapy, and the second one 12 hours after the first. Two 1mg tablets of Granisetron are taken within 1 hour of radiation for radiation therapy. This drug should be stored between 20°C to 26°C, protected from light, and kept in its carton until the time of use. The manufacturing details and dosage information can be found in the accompanying prescribing information.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.